Aethlon Aims To Lure Drug Makers To Device Biz With Disease-Filtering Technology
This article was originally published in The Pink Sheet Daily
Executive Summary
CEO Jim Joyce says firm is in early discussions with several drug companies about prospects to partner on product development with the newly introduced Aethlon ADAPT filtration platform technology.